NCT01369433 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsAVEO Pharmaceuticals, Inc.Phase NA Terminated225 enrolled 7 charts
NCT01705106 2018-05-30Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard TherapiesUniversity of ChicagoPhase 1 Terminated21 enrolled 5 charts